TrialCancer control : journal of the Moffitt Cancer Center

A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.